| Literature DB >> 32344929 |
Beata Krawczyk1, Michał Michalik2, Magdalena Fordon1, Magdalena Wysocka1, Alfred Samet2, Bogdan Nowicki3.
Abstract
Escherichia coli were isolated from three patients with chronic rhinosinusitis (CRS) by intraoperative sinus tissue biopsy. Taking into account the unusual replicative niche and previous treatment failures, it was decided to focus on the virulence and drug resistance of these bacteria. The strains turned out to be multi-sensitive, but the rich virulence factors profile of bacteria typical for phylogenetic group B2 deserved attention. Tests were carried out for the presence of 32 genes using the PCR method. Particularly noteworthy are the toxins Cnf-1, HlyA, Usp-an extensive iron uptake system (enterobactin, salmochelin, yersiniabactin and outer membrane hemin receptor ChuA)-SPATE autotransporters such as vat and pic, Ag43 autoaggregative protein-important for biofilm formation-and TosA/B which enhance the fitness of E.coli. All these virulence factors are identified predominantly in UPEC strains and provide a fitness advantage during colonization of the sinuses. Patients with CRS should be asked for past or present UTI. The specific virulence factors of E. coli that facilitate the colonization of the GI tract and urinary tract may also favor the colonization of a new ecological niche (sinuses) as a result of microbial imbalance or dysbiosis.Entities:
Keywords: E.coli; UPEC; biopsy; chronic rhinosinusitis; virulence factors
Year: 2020 PMID: 32344929 PMCID: PMC7280992 DOI: 10.3390/pathogens9050318
Source DB: PubMed Journal: Pathogens ISSN: 2076-0817
Clinical and microbiological characteristics of patients.
| Clinical Characteristic of Patients | Case 1 | Case 2 | Case 3 |
|---|---|---|---|
|
| |||
| Age | 41 | 44 | 18 |
| Gender | M | M | M |
| Underlying diseases | chronic sinusitis | chronic sinusitis | chronic sinusitis |
| Duration of illness | 7 years | 3 years | 5 years |
| Duration of symptoms | >12 weeks | >12 weeks | >12 weeks |
| Episodes within a one-year period | >4 | >4 | >4 |
|
| |||
| Purulent drainage | + | + | + |
| Facial/dental pain | + | + | + |
| Nasal obstruction | + | + | + |
| Hyposmia | + | + | + |
| Nasal congestion | + | − | + |
| Halitosis | + | − | - |
| Cough, sore throat | + | + | + |
| Ear pain | − | − | + |
|
| |||
| Nasal polyps | + | − | + |
| Lower nasal concha hypertrophy | − | + | + |
| Cigarette smoking: Currently (C)/in the past (P) | + (P) | + (P) | + (P) |
| Sleep apnea | - | + | - |
| Allergy | + | - | - |
| Snoring | − | − | − |
| GERD | − | − | − |
| * Outpatient procedures within 6 months in violation of tissue integrity | dental treatment | - | - |
| Surgery | functional endoscopic sinus surgery | functional endoscopic nasal and nasal sinuses surgery, nasal segmental correction, correction of soft palate by coblation method | functional endoscopic sinus surgery, correction of nasal septum and conchae by coblation method |
| CBCT 3D | CBCT 3D | CBCT 3D | |
| Radiodiagnostics | |||
|
| |||
| Relapse | + | − | − |
| Duration of clinical remission | 6 months | − | − |
|
| functional endoscopic sinus surgery with the opening of ethmoid cells, frontal sinuses | − | − |
|
| |||
| Polypoid mucosal | + | − | + |
| Cylindrical epithelium | − | + | + |
| Infiltration with monocytes | − | + | + |
| Metaplasia | − | − | − |
| Blood count/NEU% [range 45–70] | 64 | 51.7 | 51.5 |
| Blood count/EOS% | 4.9 | 2.7 | 6.3 |
| Blood count/MONO% [range 3–8] | 9.4 | 8.5 | 5.4 |
| Clinical sample | specimen/swab | specimen/swab | specimen/swab |
|
| |||
| Polymicrobial infections |
|
|
|
| Empiric Therapy | AMC | AMC | AMC |
| Inflammation of the urinary system | + | + | + |
| Episodes/ recurrence of infection | >10/+ | 2/− | 1/− |
Legend: AMC, amoxycillin/clavulanic acid; EOS%, percentage of eosinophils; NEU%, percentage of neutrophils; MONO%, percentage of monocytes; GERD, Gastroesophageal reflux disease; M, male; CBCT 3D - Cone beam computed tomography. * This item presents all outpatient procedures within 6 months related to violation of tissue continuity, minor surgical, dental, aesthetic medicine procedures, implants, ear piercing, etc.
Genetic characteristic of E. coli isolates.
| Genetic Characteristic of Isolates | Isolate 1 | Isolate 2 | Isolate 3 |
|---|---|---|---|
|
| from left maxillary sinus | from right maxillary sinus | from left maxillary sinus |
| Antibiotic resistance profile of | - | AM, AMC, P, AMX, TRC, TR | - |
| Virulence -associated genes of | |||
| Adhesins (fimbrial and nonfimbrial adhesin) | |||
| Toxins | |||
| Iron acquisition system | fyuA, irp2, | ||
| K capsule | |||
| Autotransporter and biofilm | |||
| Serine protease autotransporters | |||
| Invasin | - | - | |
| B2 | B2 | B2 | |
Legend: AM: ampicillin; AMC: amoxycillin/clavulanic acid; P: piperacillin; AMX: amoxycillin; TR: ticarcillin; TRC: ticarcillin/clavulanic acid; fimG/fimH, type 1 fimbriae; sfaD/sfaE, S fimbriae; papC/G, P fimbriae; focG, F1C fimbriae; hlyA, α-hemolysin; cnf1, cytotoxic necrotizing factor 1; usp, uropathogenic specific protein; kspMTII, synthesis capsule; iha, enterobactin iha-iron-regulated gene homologue adhesion; fyuA, yersiniabactin receptor; irp2, yersiniabactin gene synthesis; fepA, enterobactin receptor; entB, enterobactin gene synthesis; iroN, salmochelin receptor; chuA, outer membrane hemin receptor; fecA, ferric citrate outher membranę transporter; ibeA, invasion of brain endothelium A; ag43a, biofilm formation with autotransporter protein function simultaneous; vat, vacuolating autotransporter toxin; pic, serine protease autotransporter; tosA, nonfimbrial adhesin; tosB, ABC-transporter protein of the HlyB family; ibeA, invasion, macrophage survival, inflammatory response.
Figure 1Analysis of genomic DNA of E. coli by LM-PCR/Shifter method. The genotypes indicate different fingerprint patterns for E. coli strains. 1. Pattern of UPEC clinical strain unrelated with patients; 2. pattern for E. coli strain isolated from Patient I; 3. pattern for E. coli strain isolated from Patient II; 4. pattern of E. coli strain from Patient III. M- the molecular DNA size marker (100–1000 bp).